ABI
COR icon

Adamant Biomedical Investments’s Cencora COR Stock Holding History

Adamant Biomedical Investments’s Portfolio COR Stock Details COR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$902K Hold
10,000
– – 0.22% 84
2014
Q3 		$773K Buy
+10,000
New +$760K 0.19% 83

Other funds holding COR

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Adamant Biomedical Investments's COR Position: Q4 2014 in Review

Adamant Biomedical Investments held its Cencora (COR) position steady in Q4 2014 at 10,000 shares worth $902K. The position accounts for 0.22% of the portfolio, ranked #84.

Adamant Biomedical Investments first reported a position in COR in Q3 2014 and has held it in 2 quarters since. 657 funds tracked by Wall St. Rank hold COR as of Q4 2014.

  • Adamant Biomedical Investments held 10,000 shares of Cencora worth $902K as of Q4 2014.
  • Adamant Biomedical Investments left its Cencora share count unchanged in Q4 2014.
  • Cencora made up 0.22% of Adamant Biomedical Investments's portfolio in Q4 2014, its #84 holding.
  • Adamant Biomedical Investments first reported a position in Cencora in Q3 2014 and has held it in 2 quarters since.
  • 657 funds tracked by Wall St. Rank held Cencora as of Q4 2014.

Based on Adamant Biomedical Investments's 13F filing for Q4 2014, filed 13 Feb 2015.